About Keck Medicine of USC Huntington Beach
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Keck Medicine of USC Huntington Beach
During the past decade, Keck Medicine of USC Huntington Beach conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Induction Intensification in Treating Infants With Newly Diagnosed Acute Lymphoblastic Leukemia
1996-06-01
2012-03-01
Completed
221
Combination Chemotherapy in Treating Children With Progressive Brain Tumors
1997-04-01
2012-04-01
Completed
428
Genetic Study of Children With Soft Tissue Sarcoma or Rhabdomyosarcoma
1998-12-01
2007-03-01
Completed
294
Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Neuroblastoma
2001-02-01
Completed
495
Combination Chemotx in Treating Children or Adolescents With Newly Diagnosed Stg III or Stg IV Lymphoblastic Lymphoma
2000-06-01
2015-03-31
Completed
393
S0008: Chemotherapy Plus Biological Therapy in Treating Patients With Melanoma
2000-08-01
2012-07-01
Completed
432
Combination Chemotherapy in Treating Children With Refractory or Relapsed Hodgkin's Lymphoma
2001-05-01
2012-03-01
Completed
66
Carboxypeptidase-G2 in Treating Nervous System Toxic Effects in Patients Given an Overdose of Intrathecal Methotrexate
1993-11-01
Completed
10
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Keck Medicine of USC Huntington Beach"
#1 collaborator was "National Cancer Institute (NCI)" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Keck Medicine of USC Huntington Beach
According to Clinical.Site data, the most researched conditions in "Keck Medicine of USC Huntington Beach" are
"Acinar Cell Carcinoma" (1 trials), "Acral Lentiginous Melanoma" (1 trials), "Adenoid Cystic Carcinoma" (1 trials), "Adrenal Cortical Carcinoma" (1 trials) and "Adrenal Gland Pheochromocytoma" (1 trials). Many other conditions were trialed in "Keck Medicine of USC Huntington Beach" in a lesser frequency.
Clinical Trials Intervention Types at Keck Medicine of USC Huntington Beach
Most popular intervention types in "Keck Medicine of USC Huntington Beach" are "Procedure" (5 trials), "Biological" (4 trials), "Drug" (2 trials), "Radiation" (2 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Biospecimen Collection" (3 trials), "Computed Tomography" (2 trials), "Pembrolizumab" (2 trials), "Radiation Therapy" (2 trials) and "Active Comparator" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Keck Medicine of USC Huntington Beach
The vast majority of trials in "Keck Medicine of USC Huntington Beach" are
5 trials for "All" genders.
Clinical Trials Status at Keck Medicine of USC Huntington Beach
Currently, there are NaN active trials in "Keck Medicine of USC Huntington Beach".
undefined are not yet recruiting,
2 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in Keck Medicine of USC Huntington Beach,
1 suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Keck Medicine of USC Huntington Beach, 0 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".